ciprofibrate
Sign in to saveAlso known as WIN-35833
Ciprofibrate is a fibrate that was developed as a lipid-lowering agent.
Research
564 papers- Ciprofibrate--a profile.Postgraduate medical journal · 1993
- Ciprofibrate attenuates airway remodeling in cigarette smoke-exposed rats.Respiratory physiology & neurobiology · 2020
- A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate.Journal of pharmaceutical sciences · 2024
- Efficacy and safety of ciprofibrate in hyperlipoproteinaemias.Atherosclerosis · 1996
- Ciprofibrate regulation of rat hepatic bilirubin glucuronidation and UDP-glucuronosyltransferases expression.European journal of drug metabolism and pharmacokinetics · 2012
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 288.032
- Has use
- medication
Show 4 more facts
- chemical formula
- C₁₃H₁₄Cl₂O₃
- canonical SMILES
- CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
- World Health Organisation international non-proprietary name
- ciprofibrate
- significant drug interaction
- pravastatin
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Ciprofibrate is a fibrate that was developed as a lipid-lowering agent.
It was patented in 1972 and approved for medical use in 1985.
Excerpted from Wikipedia’s “ciprofibrate” article, available under the CC BY-SA 4.0 licence.
Available in 12 languages
- Français
- Português
- العربية
- Bahasa Indonesia
- Nederlands
- Polski
- Romanian
- Serbian
- Serbian (Latin)
- Tiếng Việt
- فارسی
via Wikidata sitelinks · CC0